在树突细胞中通过mRNAm6A甲基化和YTHDF1控制的抗瘤免疫力
Dali Han1,2,3, Jun Liu4,5,6, Chuanyuan Chen7,8,9
1Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China. handl@big.ac.cn.
Nature
|February 8, 2019
概括
由YTHDF1调节的信使RNA (mRNA) N6甲基氨酸 (m6A) 甲基化控制了持久的抗瘤免疫力. 缺少YTHDF1会增加CD8+T细胞的反应,并提高免疫疗法的有效性.
科学领域:
- 免疫学
- 分子生物学
- 癌症研究
背景情况:
- 瘤新抗原对抗瘤免疫力和免疫治疗反应至关重要.
- 尽管存在新抗原,但由于免疫反应不足,瘤的完全消除往往受到限制.
研究的目的:
- 研究mRNAN6甲基氨酸 (m6A) 甲基化和YTHDF1在调节抗瘤免疫力的作用.
- 探索YTHDF1对新抗原呈现和T细胞反应的影响.
主要方法:
- 对Ythdf1缺乏和野生型小鼠的比较分析.
- 在树突细胞中评估CD8+T细胞反应和瘤抗原交叉呈现.
- 研究YTHDF1的机制,其中包括m6A标记的转录和 lysosomal cathepsins.
主要成果:
- 缺少Ythdf1的小鼠表现出增强的抗原特异性CD8+T细胞抗瘤反应.
- 树突细胞中的YTHDF1损失改善了瘤抗原交叉呈现和T细胞交叉化.
- YTHDF1结合了多个A标记的转录,增加了甲素翻译和抑制了抗原交叉呈现.
结论:
- YTHDF1通过m6A甲基化调节持久的新抗原特异性免疫.
- 向YTHDF1增强了抗瘤CD8+T细胞的反应和PD- L1免疫疗法的有效性.
- YTHDF1代表了改善癌症免疫治疗的潜在治疗标.
相关概念视频
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Epigenetic Regulation
33.0K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.0K
Epigenetic Regulation
3.6K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.6K
mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
MicroRNAs
3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs
23.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K


